1999
DOI: 10.1126/science.283.5400.357
|View full text |Cite|
|
Sign up to set email alerts
|

Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIV

Abstract: Current recombinant human immunodeficiency virus (HIV) gp120 protein vaccine candidates are unable to elicit antibodies capable of neutralizing infectivity of primary isolates from patients. Here, "fusion-competent" HIV vaccine immunogens were generated that capture the transient envelope-CD4-coreceptor structures that arise during HIV binding and fusion. In a transgenic mouse immunization model, these formaldehyde-fixed whole-cell vaccines elicited antibodies capable of neutralizing infectivity of 23 of 24 pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
102
0
1

Year Published

2000
2000
2004
2004

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 204 publications
(104 citation statements)
references
References 45 publications
1
102
0
1
Order By: Relevance
“…In this study we have used immunogens in different combinations that contain the HIV-1 envelope gp120 and the transmembrane gp41 (gp160), a few gp41 peptides representing HIV-1-neutralizing regions, and the second external loop of the CCR5 receptor. It is known that the gp120 mediates binding and entry steps in HIV-1 infection and that the gp120-CD4 coreceptor binding induces conformational changes that activate the gp41 transmembrane regions of the envelope (32). It is also believed that the fusion structure of the envelope protein after CD4 and coreceptor binding breaks down into two coils within the gp41 monomer, and that synthetic peptides against either gp41 helical coil are able to inhibit viral infectivity (33,34).…”
Section: Discussionmentioning
confidence: 99%
“…In this study we have used immunogens in different combinations that contain the HIV-1 envelope gp120 and the transmembrane gp41 (gp160), a few gp41 peptides representing HIV-1-neutralizing regions, and the second external loop of the CCR5 receptor. It is known that the gp120 mediates binding and entry steps in HIV-1 infection and that the gp120-CD4 coreceptor binding induces conformational changes that activate the gp41 transmembrane regions of the envelope (32). It is also believed that the fusion structure of the envelope protein after CD4 and coreceptor binding breaks down into two coils within the gp41 monomer, and that synthetic peptides against either gp41 helical coil are able to inhibit viral infectivity (33,34).…”
Section: Discussionmentioning
confidence: 99%
“…Antibodies from vaccine trials using purified, native, full- length F protein have very low neutralizing activities compared with those generated by live HRSV (1). One suggested strategy for eliciting neutralizing HIV-1 antibodies is to target transient intermediates or fusion-competent conformations (39,43). The N-terminal coiled coil observed in the current structure might be formed in a prehairpin intermediate analogous to that found in HIV-1 and thus may be a viable target for antifusion antibodies.…”
Section: Discussionmentioning
confidence: 99%
“…A search for compounds that prevent the pressure-induced effects may lead to agents capable of blocking formation of the FG state. A recent study (54) describes the potential of using fusion complexes for human immunodeficiency virus vaccine development. Since high pressure is able to produce fusion-intermediate states, which are similar to that at low pH in endosomes (alphaviruses and influenza virus) or that produced by binding to receptors (such as in human immunodeficiency virus), there is a great potential to utilize the pressure approach to produce vaccines.…”
Section: Fig 5 Pressure-induced Fusogenic State Of Sindbis Virusmentioning
confidence: 99%